NLRP3 and cardiovascular disorder: In conclusion, animal models have demonstrated very robust evidence of a protective effect of NLRP3 inflammasome inhibition and the results of early clinical trials that aimed to limit the effects of the NLRP3 inflammasome in cardiovascular diseases are promising.